brain fog semaglutide and BRAIN FOG: An increasingly common problem that needs to be diagnosed and treated early Do Ozempic and Wegovy have

It's a signal of where chronic disease management is heading globally

Carboxylic acids as activators of NRF2: Antioxidant and anti-inflammatory effects

Bi vit trn l tng hp l do gii p cho thc mc c nn ung whey trong khi tp khng cng nh gi thi im ung v lu khi ung whey

Cardiovascular Outcomes Liraglutide (LEADER trial): 13% reduction in major adverse cardiovascular events (MACE) in patients with Type 2 diabetes and high cardiovascular risk Statistically significant cardiovascular protection Semaglutide (SELECT trial): 20% reduction in MACE in patients with obesity and established cardiovascular disease Studied specifically for cardiovascular outcomes in obesity (not just diabetes) Both medications provide cardiovascular protection, but semaglutides evidence is more recent, more robust, and specifically applicable to patients with obesity regardless of diabetes status

Patients should inform all healthcare professionals about both medications and report any severe side effects through the MHRA Yellow Card scheme

It is typically administered as a once-weekly subcutaneous injection in clinical studies